← Open Payments lookup

LYNNE TAVERA: Open Payments

NPI 1952442535 · BURLINGAME, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,416 in 98 payments from 17 companies in 2025. Trend: 2023 $2,418 · 2024 $1,896 · 2025 $2,416

Food & beverage: $2,416
CompanyPaymentsAmount
Gilead Sciences, Inc.10$407
Madrigal Pharmaceuticals15$373
ABBVIE INC.14$308
Janssen Biotech, Inc.8$251
Aimmune Therapeutics, Inc.13$211
Ardelyx, Inc.6$177
Takeda Pharmaceuticals U.S.A., Inc.7$176
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$159
Ipsen Biopharmaceuticals, Inc3$74
Novo Nordisk Inc3$62

Products named: REZDIFFRA, TREMFYA, ZENPEP, IBSRELA, XIFAXAN, ENTYVIO, RINVOQ, IQIRVO.

Industry payments across CA — which companies pay providers there.